By David Wild
Using a rapid molecular diagnostic assay to identify vancomycin-resistant enterococci (VRE) cut in-hospital mortality rates by nearly 80% in a study presented at IDWeek 2020 (oral abstract 10).
According to co-investigator and presenter Sarah Bandy, a pharmacy student at the University of Texas at Austin College of Pharmacy, using rapid molecular testing has been shown to abbreviate unnecessary treatment, reduce drug spending and shorten hospital stays, but “there’s not